-
公开(公告)号:WO2021243284A1
公开(公告)日:2021-12-02
申请号:PCT/US2021/034987
申请日:2021-05-28
Applicant: AMGEN INC.
Inventor: IP, Anna , PATEL, Ketaki , TALLEY, Clea , TREUHEIT, Michael J. , ZHANG, Jun
IPC: A61K39/395 , A61P7/00 , C07K16/18
Abstract: Antibody formulations and methods of making and using such formulations are provided herein. The formulation can be for intravenous administration. In some embodiments, the formulation is for subcutaneous administration. In some embodiments, the formulation comprises an anti-C5 antibody, such as eculizumab.